Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 16;12(6):636-653.
doi: 10.1016/j.cels.2021.05.015.

Advances in systems biology modeling: 10 years of crowdsourcing DREAM challenges

Affiliations
Review

Advances in systems biology modeling: 10 years of crowdsourcing DREAM challenges

Pablo Meyer et al. Cell Syst. .

Abstract

Computational and mathematical models are key to obtain a system-level understanding of biological processes, but their limitations have to be clearly defined to allow their proper application and interpretation. Crowdsourced benchmarks in the form of challenges provide an unbiased assessment of methods, and for the past decade, the Dialogue for Reverse Engineering Assessment and Methods (DREAM) organized more than 15 systems biology challenges. From transcription factor binding to dynamical network models, from signaling networks to gene regulation, from whole-cell models to cell-lineage reconstruction, and from single-cell positioning in a tissue to drug combinations and cell survival, the breadth is broad. To celebrate the 5-year anniversary of Cell Systems, we review the genesis of these systems biology challenges and discuss how interlocking the forward- and reverse-modeling paradigms allows to push the rim of systems biology. This approach will persist for systems levels approaches in biology and medicine.

Keywords: artificial intelligence; biological networks; cell lineage; crowdsourcing; modeling; neural networks; parameter estimation; promoters; single cell; systems biology; whole cell models.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.S.R. receives funding from GSK and Sanofi and consultant fees from Travere Therapeutics.

Publication types